mRNA Synthesis via IVT: A Step-by-Step Guide

Common cloning vectors like E. coli plasmids (such as pUC) contain three functional regions: an origin of replication enabling independent plasmid replication outside the bacterial cell cycle, a drug resistance gene (such as ampicillin resistance), and a multiple cloning site (polylinker) containing numerous restriction sites. The polylinker region allows insertion of foreign DNA at specific locations determined by the restriction enzyme recognition sequences.

Restriction mapping determines the locations of restriction enzyme cut sites on plasmid DNA. A plasmid is circular DNA. When cut with a single restriction enzyme, it produces linear fragments. Fragment sizes indicate distances between cut sites. For example, a 1000 bp fragment indicates a single cut site. Multiple cut sites produce multiple fragments whose sizes sum to the total plasmid length. When enzymes are combined, fragment sizes change, indicating overlapping cut sites. Unchanged fragments indicate sites not affected by the additional enzyme.

Plasmids are circular DNA molecules found in bacteria that can be genetically engineered with specific genes and restriction sites; restriction enzymes cut DNA at precise recognition sequences, enabling scientists to create restriction maps by analyzing fragment sizes from single or double enzyme digestions, which allows them to determine the relative positions and distances between restriction sites on a plasmid or linear DNA molecule.

Plasmids are circular DNA molecules naturally found in bacteria that serve as essential cloning vectors in genetic manipulation. They function by moving DNA between different species, similar to how mosquitoes transmit malaria parasites. Bacteria contain both chromosomes with essential genes and plasmids with optional genes like antibiotic resistance. Plasmids are self-replicating and range from 1,000-20,000 base pairs, making them ideal for inserting typical genes of 2,000-4,000 base pairs. Three fundamental components are required for functional plasmid vectors: (1) Origin of replication (ori) - a specific DNA sequence enabling DNA replication machinery to recognize and copy the plasmid, controlling copy number per cell (2-3 to hundreds); (2) Selectable marker - provides visible phenotype (like antibiotic resistance) to identify cells that have taken up the plasmid, since transformation efficiency is very low (~1 in 10,000 cells); (3) Multiple cloning site (MCS) - contains multiple restriction enzyme recognition sites for inserting genes of interest. The standard cloning workflow involves: (1) amplifying the gene of interest via PCR; (2) digesting both plasmid and gene with restriction enzymes; (3) purifying and ligating the fragments using DNA ligase; (4) transforming the recombinant plasmid into host cells (typically E. coli).

pBR322 is the first widely used plasmid vector in genetic engineering, discovered by polymer antrotric in the 1970s. It contains three essential elements: (1) an origin of replication (ori) derived from E. coli that enables vector replication in host cells, (2) at least 12 unique restriction sites (such as BamH1, Sal1, Pst1, Pvu1) within the selectable marker regions that allow insertion of genes of interest, and (3) two selectable markers—ampicillin resistance and tetracycline resistance genes. The vector is 4361 base pairs in length. The selectable markers enable selection of recombinant colonies through insertional inactivation: when a gene is inserted into a restriction site within a resistance gene, that gene becomes non-functional, allowing researchers to distinguish recombinant colonies (which grow only on ampicillin medium) from non-recombinant colonies (which grow on both antibiotics).

The 5' cap and poly-A tail are essential modifications for eukaryotic mRNA stability and function. The 5' cap consists of N7-methylguanosine linked via 5' to 5' triphosphate, formed co-transcriptionally by RNA triphosphatase, guanylyltransferase, and methyltransferase. It protects mRNA from ribonucleases, facilitates nuclear export, and recruits ribosomes for translation. The poly-A tail is a sequence of adenosines added by poly(A) polymerase using ATP, triggered by the AAUAAA motif recognized by CPSF. The tail length typically exceeds 200 nucleotides and serves multiple functions: protection against degradation, nuclear export facilitation, and translation promotion through recruitment of poly(A)-binding proteins.

Eukaryotic mRNA has 5' cap and 3' poly(A) tail. Cap-binding protein (CBP) interacts with poly(A)-binding protein (PABP) via eIF4G, circularizing the mRNA. eIF4A helicase unwinds secondary structures. The small subunit binds to the circular mRNA, and the large subunit joins after dissociating initiation factors. eIF2 delivers methionyl-tRNA to the P site, guided by the Kozak sequence near the start codon.

The 5' cap (7-methylguanosine) prevents 5' exonuclease degradation by being unrecognizable as a substrate. The 3' poly(A) tail shields mRNA from 3' exonucleases by being degraded first, protecting the coding sequence. Both structures determine mRNA stability and half-life; longer tails mean longer mRNA persistence in the cytoplasm, enabling more translation rounds.

Eukaryotic mRNAs undergo extensive processing including 5' capping and 3' poly(A) tail addition. The 5' cap (7-methylguanosine) protects mRNAs from degradation and aids translation. The poly(A) tail (200+ adenylates) signals nuclear export and regulates mRNA stability—the longer the tail, the more stable the mRNA. These modifications distinguish eukaryotic mRNAs from prokaryotic transcripts and contribute to their longer half-lives (24 hours vs. ~10 minutes).

The 5' cap consists of a modified guanine nucleotide (7-methylguanosine) that is linked to the first nucleotide of the mRNA. The 3' poly-A tail consists of a sequence of adenine nucleotides (typically 100-250 in length) added to the 3' end of the mRNA. The 5' cap serves as a recognition site for the ribosome during translation initiation and helps protect mRNA from degradation. The 3' poly-A tail interacts with the 5' cap through poly-A binding proteins, creating a circular structure that enhances translation efficiency. Together, these modifications protect mRNA from degradation and facilitate its export from the nucleus to the cytoplasm.

In vitro transcription is a molecular biology technique that recapitulates the transcription process outside of a living system. The process requires three main components: (1) Bacteriophage RNA polymerase (T7, T3, or SP6), with T7 being most commonly used; (2) Template DNA containing a promoter sequence and the gene of interest; (3) Ribonucleotide triphosphates (ATP, GTP, UTP, CTP) as building blocks. The polymerase binds to the promoter, reads the DNA template, and synthesizes complementary RNA. Linear DNA templates are used to define transcription endpoints. This technology allows production of large quantities of RNA needed for clinical applications, with the process being cost-effective compared to chemical synthesis.

DNA polymerases require templates and primers, cannot initiate from nothing, and extend primers by adding nucleotides through phosphodiester bond formation. Family B DNA polymerases are most significant for eukaryotic replication. RNA polymerases use the same bond formation mechanism but require double-stranded DNA templates and can initiate from zero. Eukaryotic transcription initiation is extremely complex, requiring many transcription factors. T7 RNA polymerase from bacteriophage is commonly used for in vitro applications as it requires only a promoter sequence.

T7 bacteriophage encodes its own DNA-dependent RNA polymerase, which transcribes all viral genes from the injected DNA template. This viral polymerase is about 2.5 times faster than the cellular DNA-dependent RNA polymerase. The polymerase binds to specific promoters on the viral genome to initiate transcription, producing viral proteins needed for replication and assembly.

T7 bacteriophage is a midsize DNA virus infecting E. coli with double-stranded DNA containing equal A, T, G, C bases and no unusual bases. The 39,936 bp genome has 160 bp terminal redundancy and contains 50 closely packed genes plus 5 overlapping genes. The genome demonstrates extreme economy: leaders/spacers are only a few nucleotides, and for half the genes, the Shine-Dalgarno sequence lies within the preceding gene's coding region. The life cycle follows a precise timeline: attachment at T=0, slow DNA injection (~10 minutes total), host transcription shutdown at 4 minutes, phage DNA synthesis at 8-9 minutes, first phage appearance at 15 minutes, and lysis at 25 minutes. The first gene product inhibits E. coli restriction endonuclease. Transcription is temporally regulated in two stages: early stage uses host E. coli RNA polymerase to transcribe genes 3-1.3, while late stage uses newly synthesized T7 RNA polymerase. Three classes of transcripts (1, 2, 3) are synthesized from the right strand. Class 1 transcripts use three promoters to increase synthesis rate 3-fold and are cleaved by host RNase III into five mRNA molecules encoding protein kinase and T7 RNA polymerase. Protein kinase phosphorylates E. coli RNA polymerase, inactivating it and reducing host transcription. Class 2 and 3 require T7 RNA polymerase but are made sequentially due to slow DNA injection. Class 2 transcripts code for a second inhibitor of E. coli RNA polymerase that completely shuts down host transcription. By 8 minutes post-infection, no E. coli RNA synthesis occurs. Class 2 also contains DNA replication enzymes and structural protein genes. T7 DNA replication begins bidirectionally from one end, forming concatamers that are cut to release individual progeny genomes. The product of gene 3.5 binds to T7 RNA polymerase and is responsible for overall transcription inhibition and cell lysis.

mRNA is synthesized enzymatically through in vitro transcription using linearized DNA templates. The T7 RNA polymerase (~100 kDa) is the smallest RNA polymerase requiring no cofactors. It binds promoters, separates DNA strands creating a ~14-15 base transcription bubble, incorporates capping molecules, and polymerizes RNA nucleotides through a Brownian ratchet mechanism taking ~20 microseconds per base pair. Reactions at ~37°C yield ~5g/L mRNA. Critical components include pyrophosphatase to consume pyrophosphate byproducts, all four nucleotides, capping reagents, and RNase inhibitors to prevent degradation.